Condition
Herpes Simplex
ClinicalTrials.gov condition label
Explore related research
Search across original and mapped recordsSearch results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 27 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
27 shownThe Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataNCT04239521 · 2020-10-01
COMPLETEDFeasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's DiseaseNCT02997982 · 2016-12-01
COMPLETEDValacyclovir Augmentation for Cognitive and Functional Remediation in SchizophreniaNCT01794897 · 2013-02-01
COMPLETEDCan Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?NCT01176409 · 2010-09-01
COMPLETEDPrevalence of Sexually Transmitted Infections (STIs) in HIV-infected PatientsNCT00973466 · 2009-05-01
COMPLETEDHSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and BreastfeedingNCT00530777 · 2008-04-01
COMPLETEDEpisodic Acyclovir Therapy for Genital UlcersNCT00164424 · 2005-03-01
COMPLETEDHSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsNCT00465205 · 2005-01-01
COMPLETEDHSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.NCT00378976 · 2003-08-01
COMPLETEDA Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected PersonsNCT00161434 · 2003-03-01
COMPLETEDSafety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideNCT00213031 · 2000-02-01
COMPLETEDA Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsNCT00005663 · 1999-06-01
UNKNOWNThe Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir TreatmentNCT00002144
COMPLETEDDouble-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)NCT00002186
COMPLETEDAn Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesNCT00002272
COMPLETEDA Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected PatientsNCT00002000
COMPLETEDSP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With AcyclovirNCT00002310
COMPLETEDAn Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesNCT00002021
COMPLETEDCidofovir as a Treatment for Herpes Simplex in Patients With AIDSNCT00002181
COMPLETEDA Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSNCT00002116
COMPLETEDA Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsNCT00002084
COMPLETEDThe Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsNCT00002404
COMPLETEDComparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With AcyclovirNCT00000985
COMPLETEDThe Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenNCT00001054
WITHDRAWNThe Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUNCT00000654
COMPLETEDTreatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical TrifluridineNCT00000635
COMPLETEDThe Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the BloodNCT00001115
COMPLETEDCommon interventions
AcyclovirDRUG6valacyclovirDRUG5Valacyclovir hydrochlorideDRUG5Foscarnet sodiumDRUG4placeboDRUG3CidofovirDRUG2CrofelemerDRUG2matching placeboDRUG2Bacitracin zinc/Polymyxin B sulfateDRUG1Carraguard (PC-515)DRUG1Experimental: Valacyclovir treatmentDRUG1Exposure of interest (studies 2 & 3).OTHER1FialuridineDRUG1Placebo comparatorDRUG1TrifluridineDRUG1Valaciclovir 500Mg TabletDRUG1VidarabineDRUG1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
National Institute of Allergy and Infectious Diseases (NIAID)
5
Glaxo Wellcome
4
University of Washington
4
Astra USA
3
Gilead Sciences
2
Shaman Pharmaceuticals
2
Centers for Disease Control and Prevention
1
Hugo Lovheim
1
Insel Gruppe AG, University Hospital Bern
1
Momentum Data
1
Population Council
1
University Health Network, Toronto
1
University of Pittsburgh
1
Trial status mix
COMPLETED25
UNKNOWN1
WITHDRAWN1
Phase mix
NA10
PHASE36
PHASE25
PHASE13
PHASE42
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.